Genetic Testing Decision Aid

Recruiting now · Not applicable

Conditions studied: Epithelial Ovarian Carcinoma, Pancreas Adenocarcinoma

In brief

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Key facts

Study ID

NCT05470920

Run by

Massachusetts General Hospital

People needed

350

Starts

2022-10-14

Expected to finish

2026-12-31

Last updated by the study team

2025-08-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Being seen in clinic at Massachusetts General Hospital or Boston Medical Center
• Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.

You may not qualify if…

• Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study
• Previous germline genetic testing
• History of hereditary pancreatitis
• Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
• Mass General at North Shore Cancer Center — Danvers, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.